Results 61 to 70 of about 9,366 (228)

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

open access: yesMolecular Oncology, Volume 19, Issue 6, Page 1687-1706, June 2025.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy   +12 more
wiley   +1 more source

Linfoma óseo primario

open access: yes, 2014
El linfoma primario de hueso es definido histológicamente como un linfoma extra ganglionar, afecta los huesos y puede ser desarrollado por una enfermedad sistémica.
Iniris Greca Rodríguez Santana   +2 more
core   +2 more sources

Los linfomas

open access: yesOncología, 2022
Los linfomas son proliferaciones malignas de linfocitos B o T. Identifican dos tipos de neoplasias, la enfermedad de Hodgkin (EH) y los linfomas no Hodgkin (LNH). Durante las últimas décadas se han hecho importantes progresos en la compresión de sus patogénesis, la cual está ritmada por transolcaciones cromosómicas que se presentan en el desarrollo de ...
openaire   +1 more source

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target

open access: yesHematological Oncology, Volume 43, Issue S2, June 2025.
ABSTRACT Mantle cell lymphoma (MCL) is a B‐cell malignancy characterized by t(11;14)(q13;q32) translocation and heterogeneous clinical behavior. Advances in risk stratification enabled the distinction of conventional MCL (cMCL) from non‐nodal MCL (nnMCL) subtypes, which presents with distinct biological and clinical features.
Simone Ferrero, Simone Ragaini
wiley   +1 more source

Linfoma primário de cólon: relato de caso

open access: yes, 2010
O linfoma colorretal primário é uma doença rara (0.2 a 0.6% de todas as neoplasias colônicas), apresentando pior prognóstico quando comparado com o linfoma gástrico primário ou com o adenocarcinoma do cólon.
Marcelo Maia Caixeta Melo   +10 more
core   +1 more source

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial

open access: yes
HemaSphere, Volume 10, Issue 1, January 2026.
Simone Ragaini   +23 more
wiley   +1 more source

Enhanced Disease Detection of Hairy Cell Leukaemia Through Next‐Generation Sequencing Based BRAFV600E and Phased Variant Analysis

open access: yeseJHaem, Volume 6, Issue 3, June 2025.
ABSTRACT Introduction Longitudinal disease assessment by molecular techniques is not routine in hairy cell leukaemia (HCL). Combining BRAFV600E and other genomic targets through next‐generation sequencing (NGS) with phased variant analysis is a novel approach for disease detection in this setting.
Simon Wu   +12 more
wiley   +1 more source

Linfoma no Hodgkin primario de sistema nervioso central en un paciente pediátrico sin inmunodeficiencia relacionada

open access: yesActa Pediátrica de México, 2015
El linfoma no Hodgkin primario de sistema nervioso central es una afección poco frecuente en la población pediátrica. No existen (o son pocas) las recomendaciones o estudios clínicos que sean útiles para definir la mejor opción terapéutica.
Rocío Cárdenas-Cardos   +5 more
doaj   +1 more source

Valutazione immunofenotipica del linfoma a grandi cellule B, diffuso: predizione prognostica e programmazione terapeutica.

open access: yes, 2009
La tesi descrive uno studio condotto su campioni citologici di linfoma diffuso a grand cellule che compara l'assetto fenotipico e gli aspetti prognostici della ...
ZEPPA, PIO
core  

Linfoma [PDF]

open access: yes, 2016
Nesta webpalestra será abordada a incidência e subtipos de linfoma (LNH e LH), seus principais sintomas e diagnóstico. Também serão abordadas as opções de tratamento no geral, sem especificação de medicamentos, e os cuidados necessários com pacientes ...
Telessaúde SC
core  

Home - About - Disclaimer - Privacy